Table 3 Prevalence of positive assessment test results
Problem | No | Prevalence | 95% CI |
|---|---|---|---|
Pneumococcal vaccination longer than three years ago (n = 113) | 93 | 82.3% | 65.4 to 92.0% |
Osteoporosis risk (n = 115) | 81 | 70.4% | 57.0% to 81.1% |
Urinary incontinence (n = 112) | 76 | 67.9% | 53.8% to 79.3% |
Hyperlipidemia at assessment (n = 113) | 66 | 57.4% | 46.7% to 67.4% |
Cognitive impairment (n = 114) | 63 | 55.2% | 41.7% to 68.1% |
Hearing loss (n = 114) | 58 | 50.9% | 38.7% to 62.9% |
Hypertension at assessment (n = 111) | 53 | 47.8% | 28.1 to 68.1% |
Last influenza vaccination longer than one year ago (n = 114) | 52 | 45.6% | 7.1% to 54.4% |
Fall risk or balance and gait difficulties (n = 115) | 48 | 41.7% | 34.5 to 49.4% |
Sleep disorder (n = 114) | 42 | 36.8% | 24.6% to 51.0% |
Depression (n = 114) | 34 | 29.8% | 19.1% to 43.3% |
Low vision (n = 110) | 32 | 29.1% | 13.8 to 51.3% |
Hyperglycemia at assessment (n = 112) | 28 | 25.0% | 16.2% to 36.6% |
Psychosocial deprivation (n = 113) | 8 | 7.1% | 3.1% to 15.3% |